| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Published online before print April 19, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
,
,
,
From the Department of Geriatrics,* Division of Experimental Diabetes and Aging, the BioMath Department,
and the Department of Medicine,
Division of Nephrology, Mount Sinai School of Medicine, New York, New York
@ To whom correspondence should be addressed. E-mail: helen.vlassara{at}mssm.edu.
| Abstract |
|---|
Aging is accompanied by increased oxidative stress (OS) and accumulation of advanced glycation end products (AGEs). AGE formation in food is temperature-regulated, and ingestion of nutrients prepared with excess heat promotes AGE formation, OS, and cardiovascular disease in mice. We hypothesized that sustained exposure to the high levels of pro-oxidant AGEs in normal diets (RegAGE) contributes to aging via an increased AGE load, which causes AGER1 dysregulation and depletion of anti-oxidant capacity, and that an isocaloric, but AGE-restricted (by 50%) diet (LowAGE), would decrease these abnormalities. C57BL6 male mice with a life-long exposure to a LowAGE diet had higher than baseline levels of tissue AGER1 and glutathione/oxidized glutathione and reduced plasma 8-isoprostanes and tissue RAGE and p66shc levels compared with mice pair-fed the regular (RegAGE) diet. This was associated with a reduction in systemic AGE accumulation and amelioration of insulin resistance, albuminuria, and glomerulosclerosis. Moreover, lifespan was extended in LowAGE mice, compared with RegAGE mice. Thus, OS-dependent metabolic and end organ dysfunction of aging may result from life-long exposure to high levels of glycoxidants that exceed AGER1 and anti-oxidant reserve capacity. A reduced AGE diet preserved these innate defenses, resulting in decreased tissue damage and a longer lifespan in mice.
This article has been cited by other articles:
![]() |
H. Vlassara, W. Cai, S. Goodman, R. Pyzik, A. Yong, X. Chen, L. Zhu, T. Neade, M. Beeri, J. M. Silverman, et al. Protection against Loss of Innate Defenses in Adulthood by Low Advanced Glycation End Products (AGE) Intake: Role of the Antiinflammatory AGE Receptor-1 J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4483 - 4491. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Torreggiani, H. Liu, J. Wu, F. Zheng, W. Cai, G. Striker, and H. Vlassara Advanced Glycation End Product Receptor-1 Transgenic Mice Are Resistant to Inflammation, Oxidative Stress, and Post-Injury Intimal Hyperplasia Am. J. Pathol., October 1, 2009; 175(4): 1722 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lapointe, Z. Stepanyan, E. Bigras, and S. Hekimi Reversal of the Mitochondrial Phenotype and Slow Development of Oxidative Biomarkers of Aging in Long-lived Mclk1+/- Mice J. Biol. Chem., July 24, 2009; 284(30): 20364 - 20374. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Dalal, L. Ferrucci, K. Sun, J. Beck, L. P. Fried, and R. D. Semba Elevated Serum Advanced Glycation End Products and Poor Grip Strength in Older Community-Dwelling Women J Gerontol A Biol Sci Med Sci, January 31, 2009; (2009) gln018v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cosentino, P. Francia, G. G. Camici, P. G. Pelicci, M. Volpe, and T. F. Luscher Final Common Molecular Pathways of Aging and Cardiovascular Disease: Role of the p66Shc Protein Arterioscler Thromb Vasc Biol, April 1, 2008; 28(4): 622 - 628. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cai, J. C. He, L. Zhu, X. Chen, G. E. Striker, and H. Vlassara AGE-receptor-1 counteracts cellular oxidant stress induced by AGEs via negative regulation of p66shc-dependent FKHRL1 phosphorylation Am J Physiol Cell Physiol, January 1, 2008; 294(1): C145 - C152. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |